论文部分内容阅读
目的：探讨托瑞米芬治疗Luminal型年轻乳腺癌患者临床疗效及安全性。方法：研究组给予国产托瑞米芬药物治疗；对照组患者给予进口托瑞米芬药物治疗，记录两组患者临床疗效及不良反应发生情况。结果：研究组与对照组患者近期疗效分别为93．75％、100．00％；不良反应发生率分别为31．25％、25．00％，对比结果无显著差异（P＞0．05）。结论：临床医师在对Luminal型年轻乳腺癌患者确定治疗方案时，应根据患者实际情况选择治疗药物，从而避免治疗过程中加重患者经济及心理负担，提高其治疗依从性。“,”Objective:To investigate the clinical ef icacy and safety in patients with cancer oftoremifene in the treatment of type Luminal young breast.Method:The study group were given domestic toremifene therapy;the control group were treated with import toremifene drug treatment,record and adverse reactions of the two groups of patients with clinical ef icacy occurrence.Re-sult:The study group and the control eficacy of patients were 93.75%,100%;the incidence of adverse reactions were 31.25%,25%,no significant diferences inthe results (P>0.05). Conclusion:Clinicians in the type of Luminal of young patients with breast cancer treatment,should choose the treatment according to the actual situation of patients,so as to avoid aggravating the economic and psychological burden of patients during the course of treatment,improve the treatment compliance.